 WOODSTOCK, Ga.--BUSINESS WIRE--Sonoma Pharmaceuticals, Inc. Nasdaq: SNOA, a global healthcare leader developing and producing stabilized hypochlorous acid HOCl products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its third fiscal quarter and nine months ended December 31, 2020. We continue to effectively execute our business plan of increasing revenue while reducing our expense 